|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Departments of Medicine (Cardiology) and Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, PA, USA
* To whom correspondence should be addressed. E-mail: kmonahan{at}psu.edu.
Animal studies suggest that prostanoids (i.e., such as prostacyclin) may sensitize or impair baroreceptor/baroreflex responsiveness depending on the site of administration/inhibition. We tested the hypothesis that acute inhibition of cyclooxygenase (COX), the rate-limiting enzyme in prostanoid synthesis, impairs baroreflex regulation of cardiac period (R-R interval) and muscle sympathetic nerve activity (MSNA) in humans and augments pressor reactivity. Baroreflex sensitivity (BRS) was determined at baseline (pre) and 60 min after (post) intravenous infusion of a COX antagonist (ketorolac; 45 mg) (24±1 yr; n=12) or saline (25±1 yr; n=12). BRS was assessed using the modified Oxford technique (bolus intravenous infusion of nitroprusside followed by phenylephrine). BRS was quantified as the slope of the linear portion of the: 1) R-R intervalsystolic
blood pressure relation (cardiovagal BRS) and 2) MSNA-diastolic blood pressure relation (sympathetic BRS) during pharmacological changes in arterial blood pressure. Ketorolac did not alter cardiovagal (19.4±2.1 vs. 18.4±2.4 ms/mmHg pre and post, respectively) or sympathetic BRS (-2.9±0.7 vs. -2.6±0.4 au/beat/mmHg), but significantly decreased a plasma biomarker of prostanoid generation (plasma thromboxane B2) by 53±11%. Cardiovagal BRS (21.3±3.8 vs. 21.2±3.0 ms/mmHg), sympathetic BRS (-3.4±0.3 vs. -3.2±0.2 au/beat/mmHg), and thromboxane B2 (
-1±12%) were unchanged in the control (saline infusion) group. Pressor responses to steady state incremental (0.5, 1.0, and 1.5 µg/kg/min) infusion (5 min/dose) of phenylephrine were not altered by ketorolac (n=8). Collectively, these data indicate that acute pharmacological antagonism of the COX enzyme does not impair BRS (cardiovagal or sympathetic) or augment pressor reactivity in healthy young adults.
This article has been cited by other articles:
![]() |
D. Wang, V. V. Patel, E. Ricciotti, R. Zhou, M. D. Levin, E. Gao, Z. Yu, V. A. Ferrari, M. M. Lu, J. Xu, et al. Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function PNAS, May 5, 2009; 106(18): 7548 - 7552. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kanbar, B. Chapuis, V. Orea, C. Barres, and C. Julien Baroreflex control of lumbar and renal sympathetic nerve activity in conscious rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R8 - R14. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cui, R. Moradkhan, V. Mascarenhas, A. Momen, and L. I. Sinoway Cyclooxygenase inhibition attenuates sympathetic responses to muscle stretch in humans Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2693 - H2700. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Momen, J. Cui, P. McQuillan, and L. I. Sinoway Local prostaglandin blockade attenuates muscle mechanoreflex-mediated renal vasoconstriction during muscle stretch in humans Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2184 - H2190. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cui, P. McQuillan, A. Momen, C. Blaha, R. Moradkhan, V. Mascarenhas, C. Hogeman, A. Krishnan, and L. I. Sinoway The role of the cyclooxygenase products in evoking sympathetic activation in exercise Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1861 - H1868. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Monahan, D. J. Dyckman, and C. A. Ray Effect of acute hyperlipidemia on autonomic and cardiovascular control in humans J Appl Physiol, July 1, 2007; 103(1): 162 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Monahan, U. A. Leuenberger, and C. A. Ray Aldosterone impairs baroreflex sensitivity in healthy adults Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H190 - H197. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Monahan, U. A. Leuenberger, and C. A. Ray Effect of repetitive hypoxic apnoeas on baroreflex function in humans J. Physiol., July 15, 2006; 574(2): 605 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. O. Salgado, S. V. S. Justo, L. F. Joaquim, R. Fazan Jr., and H. C. Salgado Role of nitric oxide and prostanoids in attenuation of rapid baroreceptor resetting Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1059 - H1063. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |